The global at-home testing kits market has witnessed significant growth in recent years. These testing kits provide consumers with the convenience of conducting various medical and diagnostic tests from the comfort of their homes. With advancements in technology and increased awareness about personal health monitoring, at-home testing kits have become a popular choice. They offer privacy, cost-effectiveness, and timely results, empowering individuals to take charge of their health and well-being. The market encompasses a wide range of testing kits for conditions such as fertility, infectious diseases, pregnancy, diabetes, and genetic testing.
Access Full Report @ https://www.databridgemarketresearch.com/ar/reports/global-at-home-testing-kits-market
Data Bridge Market Research analyses that the At-Home Testing Kits Market is expected to reach USD 13,775.51 million by 2029 from USD 8,900.44 million in 2021 growing with a healthy CAGR of 6.1% in the forecast period of 2022 to 2029. The rise of e-commerce platforms and online marketplaces has made at-home testing kits more accessible to consumers worldwide. These platforms provide a convenient means of purchasing testing kits, expanding the market reach and customer base.
Key Findings of the Study
Increasing awareness and demand for preventive care is expected to drive the market's growth rate
The increasing awareness and demand for preventive care have driven the adoption of at-home testing kits. Detecting potential health issues early, individuals can seek timely medical intervention, make necessary lifestyle changes, and engage in preventive measures to mitigate the risks associated with certain diseases, leading to improved overall health outcomes.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022-2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit, and Others), Type (Cassette, Strip, Midstream, Test Panel, Dip Card, and Others), Age (Pediatric, Adult, and Geriatric), Sample Type (Urine, Blood, Saliva, and Other Sample Types), Usage (Disposable and Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket and Online Pharmacies)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Abbott (U.S.), Siemens Healthcare GmbH (Germany), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S.), Drägerwerk AG & Co. KGaA (Germany), LifeScan IP Holdings, LLC (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), Nectar Lifesciences Ltd. (India), ACON Laboratories, Inc. (U.S.), Quidel Corporation (U.S.), ARKRAY USA, Inc. (U.S.), BTNX INC. (Canada), Atomo Diagnostics (Australia), Eurofins Scientific (Luxembourg), Piramal Enterprises Ltd. (India), Bionime Corporation (Taiwan), Nova Biomedical (U.S.), Cardinal Health (U.S.), OraSure Technologies (U.S.), Biolytical Laboratories Inc. (Canada), Everlywell, Inc. (U.S.), SA Scientific Ltd. (U.K.), Clearblue (Switzerland), Biosynex (France), PRIMA Lab SA (Switzerland), MP Biomedicals (U.S.), Sterilab Services (Spain), Chembio Diagnostics, Inc. (U.S.), BioSure (U.K.), Selfdiagnostics OU (Estonia), among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The at-home testing kits market is segmented on the basis of test type, type, age, and sample type, usage, and distribution channels.
- On the basis of test type, the global at-home testing kits market is segmented into pregnancy test, HIV test kit, diabetes, infectious diseases, glucose tests, ovulation predictor test kit, drug abuse test kit and other test types. In 2022, glucose test type is dominating the global At-Home Testing Kits market with a CAGR of 6.2% in the forecast period of 2022 to 2029 due to measure glucose levels in blood or urine to monitor and manage conditionmeasuringas diabetes or hypoglycaemia.
In 2022, glucose test type is dominating the test type segment of the global at-home testing kits market
In 2022, glucose test type is dominating the global at-home testing kits market owing to monitoring and treatment conditions such as diabetes or hypoglycemia, glucose levels in the blood or urine are measured with a CAGR of 6.2% in the forecast period of 2022 to 2029
- On the basis of type, the global at-home testing kits market is segmented into the cassette, strip, midstream, test panel, dip card, and other form types. In 2022, the strip segment is dominating the at-home testing kits market with a CAGR of 6.5% in the forecast period of 2022 to 2029 due to its ease of use, cost-effectiveness, and versatility across various testing applications. The strip format is widely adopted for its simplicity and reliability, making it the preferred choice for many consumers and healthcare professionals.
- On the basis of age, the global at-home testing kits market is segmented into pediatric, adult and geriatric. In 2022, the adult segment is dominating the at-home testing kits market with a CAGR of 6.4% in the forecast period of 2022 to 2029 due to the larger population size and higher healthcare needs compared to pediatric and geriatric age groups. Adults are more likely to use at-home testing kits for various health monitoring purposes.
- On the basis of sample type, the global at-home testing kits market is segmented into urine, blood, saliva, and other sample types. In 2022, blood type is dominating the at-home testing kits market with a CAGR of 6.3%in the forecast period of 2022 to 2029 due to its ease of collection, non-invasive nature, and the ability to provide valuable information about various health conditions.
- On the basis of usage, the global at-home testing kits market is segmented into disposable and reusable. In 2022, the disposable segment is dominating the at-home testing kits market with a CAGR of 5.8% in the forecast period of 2022 to 2029 due to its accessibility, cleanliness, and simplicity. For accurate and hassle-free testing for individuals, disposable kits do not require cleaning or sterilization.
In 2022, the disposable segment is dominating the usage segment of the at-home testing kits market
In 2022, the disposable segment is dominating the at-home testing kits market owing to its convenience, hygiene, and ease of use. Disposable kits eliminate the need for cleaning or sterilization, ensuring accurate and hassle-free testing for individuals with a CAGR of 5.8% in the forecast period of 2022 to 2029
- On the basis of distribution channels, the global at-home testing kits market is segmented into retail pharmacies, drug store, supermarket/hypermarket, and online pharmacies. In 2022, Retail pharmacies are dominating the At-home testing kits market with a CAGR of 6.0%in the forecast period of 2022 to 2029 due to the wide range of testing kits, knowledgeable staff, and provide direct access to healthcare professionals, making them a preferred choice for consumers seeking at-home testing solutions.
Major Players
Data Bridge Market Research recognizes the following companies as the major at-home testing kits market players in at-home testing kits market are Abbott (U.S.), Siemens Healthcare GmbH (Germany), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S.), Drägerwerk AG & Co. KGaA (Germany), LifeScan IP Holdings, LLC (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), Nectar Lifesciences Ltd. (India), ACON Laboratories, Inc. (U.S.), Quidel Corporation (U.S.)
Market Developments
- In 2021, The U.S. Food and Drug Administration approved the Flowflex COVID-19 Antigen Home Test for use in emergencies, according to ACON Laboratories, Inc. This will assist the business in expanding its product line and global market presence.
- In 2021, Viatris and Atomo Diagnostics had agreed to assist Unitaid in their mission to increase the availability of HIV self-testing in Low and Middle-Income Countries (LMIC). The expansion program of Unitaid will fund the distribution of up to one million HIV self-test kits, with pledges to make testing accessible in 135 nations.
- In 2020, OraSure Technologies, Inc. and The Biomedical Advanced Research and Development Authority (BARDA) and Bethlehem have partnered again for the development of an in vitro (laboratory) diagnostic to detect antibodies for the SARS-CoV-2 virus in oral fluids. With this partnership, the company will develop advanced rapid diagnostic test for the current pandemic and increase their business.
Regional Analysis
Geographically, the countries covered in the at-home testing kits market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in the at-home testing kits market during the forecast period 2022-2029
North America's dominance in the global at-home testing kits market can be attributed to several factors. The region has a robust healthcare infrastructure and high healthcare expenditure, which fosters the adoption of advanced healthcare solutions such as at-home testing kits. Additionally, the increasing awareness among the population about the benefits of at-home testing for early detection of diseases has contributed to the market's growth. These factors, coupled with a favorable regulatory environment, position North America as a leading market for at-home testing kits.
For more detailed information about the at-home testing kits market report, click here – https://www.databridgemarketresearch.com/ar/reports/global-at-home-testing-kits-market
